Details for New Drug Application (NDA): 072421
✉ Email this page to a colleague
NDA 072421 describes AMOXAPINE, which is a drug marketed by Chartwell Rx, Watson Labs, and Watson Pharms Teva, and is included in six NDAs. It is available from two suppliers. Additional details are available on the AMOXAPINE profile page.
The generic ingredient in AMOXAPINE is amoxapine. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
The generic ingredient in AMOXAPINE is amoxapine. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
Summary for 072421
| Tradename: | AMOXAPINE |
| Applicant: | Watson Pharms Teva |
| Ingredient: | amoxapine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072421
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
| Approval Date: | May 11, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
